Bayer HealthCare launches Jetstream Atherectomy System

Bayer HealthCare has announced the European launch of the Jetstream Atherectomy System, a device for use in the treatment of peripheral artery disease.

The product can be used to treat a wide range of vessel diameters and features continuous active aspiration, as well as unique technology allowing its use in thrombus, soft plaque and calcified lesions.

Its Jetstream Navitus catheter is designed for enhanced flexibility in complex anatomy, while also featuring an expandable blade technology to treat blockages in vessels from the superficial femoral artery to below the knee with a single device.

The launch complements existing Bayer HealthCare brands that are already available for sale on the European market, including the Medrad Mark 7 Arterion fluid delivery system and AngioJet thrombectomy devices.

Alan Main, president of Bayer HealthCare Medical Care, said: "The addition of the Jetstream technology demonstrates Bayer's comprehensive approach and commitment to offer treatment options to the estimated 27 million people in Europe and North America who have peripheral artery disease."

The Bayer HealthCare business saw its sales rise by ten percent year over year in the second quarter of 2012, helping to drive growth across the entire Bayer group.